Atossa Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $31,377,000.
Profit Margin
| 2014 | 525.95K | -14.65M | -2786.92% |
|---|---|---|---|
| 2015 | 1.75K | -15.76M | -896491.64% |
| 2016 | 0 | -6.36M | |
| 2017 | 0 | -8.12M | |
| 2018 | 0 | -11.40M | |
| 2019 | 0 | -17.23M | |
| 2020 | 0 | -21.09M | |
| 2021 | 0 | -20.60M | |
| 2022 | 0 | -26.22M | |
| 2023 | 0 | -30.09M |
ATOS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.75K | 525.95K |
Cost of revenue | 23K | 8K | 23K | 46.6K | 52.78K | 0 | 128.99K | 0 | 132.41K | 340.65K |
Gross profit | -23K | -8K | -23K | -46.6K | -52.78K | 0 | -128.99K | 0 | -130.65K | 185.29K |
Operating exp. | ||||||||||
Research and development | 17.33M | 15.08M | 9.21M | 6.60M | 6.64M | 4.20M | 2.32M | 770.42K | 2.35M | 2.57M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.42M | 1.27M |
Total operating expenses | 31.37M | 27.69M | 20.52M | 14.60M | 17.26M | 11.43M | 7.18M | 7.24M | 12.62M | 12.47M |
Operating income | -31.37M | -27.69M | -20.52M | -14.60M | -17.26M | -11.43M | -7.64M | -7.96M | -12.75M | -14.64M |
Other income (expenses), net | 1.28M | 731K | -85K | -3.22M | 25.64K | 29.29K | -473.41K | 880.73K | 431 | -2.48M |
Income before tax | -30.09M | -26.96M | -20.60M | -17.82M | -17.23M | -11.40M | -8.12M | -6.36M | -12.75M | -14.65M |
Income tax expense | 0 | -731K | 0 | 3.27M | 0 | -29.29K | 742.46K | -1.76M | 3.00M | 2.35M |
Net income | -30.09M | -26.22M | -20.60M | -21.09M | -17.23M | -11.40M | -8.12M | -6.36M | -15.76M | -14.65M |
Earnings per share | ||||||||||
Basic EPS | -0.24 | -0.21 | -0.18 | -1.87 | -2.03 | -2.74 | -8.33 | -25.93 | -99.79 | -109.76 |
Diluted EPS | -0.24 | -0.21 | -0.18 | -1.87 | -2.03 | -2.74 | -8.33 | -25.93 | -99.79 | -109.76 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |